120 related articles for article (PubMed ID: 37805983)
1. Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study.
Wu W; Chen Y; Wu K; Zheng H; Chen G; Wang X; Huang Z; Cai Z; Cai Z; Chen Z; Lan Y; Chen S; Wu S; Chen Y
Clin Exp Hypertens; 2023 Dec; 45(1):2264540. PubMed ID: 37805983
[TBL] [Abstract][Full Text] [Related]
2. Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study.
Wu W; Chen G; Wu K; Zheng H; Chen Y; Wang X; Huang Z; Cai Z; Cai Z; Chen Z; Lan Y; Chen S; Wu S; Chen Y
Cardiovasc Diabetol; 2023 Sep; 22(1):258. PubMed ID: 37735420
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease.
Abdullah SM; Defina LF; Leonard D; Barlow CE; Radford NB; Willis BL; Rohatgi A; McGuire DK; de Lemos JA; Grundy SM; Berry JD; Khera A
Circulation; 2018 Nov; 138(21):2315-2325. PubMed ID: 30571575
[TBL] [Abstract][Full Text] [Related]
4. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
5. Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density lipoprotein-high participants.
Kim HJ; Jeong S; Oh YH; Park SJ; Cho Y; Park SM
Cardiovasc Diabetol; 2023 Mar; 22(1):71. PubMed ID: 36978181
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
[TBL] [Abstract][Full Text] [Related]
7. Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease: The Japan Epidemiology Collaboration on Occupational Health Study.
Hu H; Fukunaga A; Yokoya T; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Miyamoto T; Sasaki N; Ogasawara T; Gonmori N; Yamamoto K; Hori A; Tomita K; Nagahama S; Konishi M; Katayama N; Morioka H; Kabe I; Mizoue T; Dohi S
J Atheroscler Thromb; 2022 Sep; 29(9):1295-1306. PubMed ID: 34690212
[TBL] [Abstract][Full Text] [Related]
8. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
[TBL] [Abstract][Full Text] [Related]
9. The association between low-density and non-high-density lipoprotein cholesterol with incident cardiovascular disease among low-risk Iranians during 2 decades follow-up.
Tohidi M; Asgari S; Chary A; Azizi F; Hadaegh F
Clin Biochem; 2022; 109-110():28-36. PubMed ID: 35970222
[TBL] [Abstract][Full Text] [Related]
10. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
[TBL] [Abstract][Full Text] [Related]
11. Combined association of lipids and blood pressure in relation to incident cardiovascular disease in the elderly: the cardiovascular health study.
Wong ND; Lopez VA; Roberts CS; Solomon HA; Burke GL; Kuller L; Tracy R; Yanez D; Psaty BM
Am J Hypertens; 2010 Feb; 23(2):161-7. PubMed ID: 19927131
[TBL] [Abstract][Full Text] [Related]
12. Relationship between lipoprotein subfraction cholesterol and residual risk for cardiovascular outcomes: A post hoc analysis of the AIM-HIGH trial.
Toth PP; Jones SR; Slee A; Fleg J; Marcovina SM; Lacy M; McBride R; Boden WE
J Clin Lipidol; 2018; 12(3):741-747.e11. PubMed ID: 29627296
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein cholesterol and cardiovascular disease in Spanish hypertensive women. The RIMHA study.
Coca A; Cea-Calvo L; Lozano JV; Inaraja V; Fernández-Pérez C; Navarro J; Bonet A; Redón J;
Rev Esp Cardiol; 2009 Sep; 62(9):1022-31. PubMed ID: 19712623
[TBL] [Abstract][Full Text] [Related]
14. Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002-2012).
Kouvari M; Panagiotakos DB; Chrysohoou C; Georgousopoulou EN; Tousoulis D; Pitsavos AC
Molecules; 2020 Mar; 25(7):. PubMed ID: 32225033
[TBL] [Abstract][Full Text] [Related]
15. Serum non-high-density lipoprotein cholesterol concentration and risk of death from cardiovascular diseases among U.S. adults with diagnosed diabetes: the Third National Health and Nutrition Examination Survey linked mortality study.
Li C; Ford ES; Tsai J; Zhao G; Balluz LS; Gidding SS
Cardiovasc Diabetol; 2011 May; 10():46. PubMed ID: 21605423
[TBL] [Abstract][Full Text] [Related]
16. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
Nichols GA; Vupputuri S; Rosales AG
Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults.
Bilhorn KR; Luo Y; Lee BT; Wong ND
Am J Cardiol; 2012 Nov; 110(10):1464-7. PubMed ID: 22858184
[TBL] [Abstract][Full Text] [Related]
18. Use of the plasma triglyceride/high-density lipoprotein cholesterol ratio to identify cardiovascular disease in hypertensive subjects.
Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; Leiva Sisnieguez BC; March CE; Stavile RN; Balbín E; Reaven GM
J Am Soc Hypertens; 2014 Oct; 8(10):724-31. PubMed ID: 25418494
[TBL] [Abstract][Full Text] [Related]
19. Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study.
Hirata A; Sugiyama D; Watanabe M; Tamakoshi A; Iso H; Kotani K; Kiyama M; Yamada M; Ishikawa S; Murakami Y; Miura K; Ueshima H; Okamura T;
J Clin Lipidol; 2018; 12(3):674-684.e5. PubMed ID: 29506864
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein cholesterol and cardiovascular mortality: a prospective cohort study among 15.8 million adults.
Yi SW; Park HB; Jung MH; Yi JJ; Ohrr H
Eur J Prev Cardiol; 2022 May; 29(5):844-854. PubMed ID: 34971388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
